Andrew Brangan
0000-0002-6196-145X
11 papers found
Refreshing results…
Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study
Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach
Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative
Patient experiences align with the familial hypercholesterolemia global call to action
Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
Common Treatment, Common Variant: Evolutionary Prediction of Functional Pharmacogenomic Variants
Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis
The Genomics of Opioid Addiction Longitudinal Study (GOALS): study design for a prospective evaluation of genetic and non-genetic factors for development of and recovery from opioid use disorder
Individuals with CYP2C8 and CYP2C9 reduced metabolism haplotypes self-adjusted ibuprofen dose in the Coriell Personalized Medicine Collaborative
Missing publications? Search for publications with a matching author name.